Next investors Established tech company that is undervaluedONE...

Next investors
Established tech company that is undervalued

ONE offers a subscription software model to hospitals and multi-year contracts that have already generated strong annual recurring revenue for the company.

Selling enterprise technology to hospitals is a very long and difficult process.

Hospitals are slow to move and the technology needs to be very solid to establish trust and track record.

But once a company does make a sale, this revenue can be very ‘sticky’. Large organisations like hospitals can also be slow or reluctant to cancel a contract related to technology embedded in their processes.

We have been investing in SaaS (Software as a Service) for many years and learnt many lessons along the way. We know huge value potential when we see it.

• ONE is currently used in 9,259 hospital beds around the world, including three of the top 20 hospitals in the USA - this footprint would have taken YEARS to build.
• ONE generated €5.1M ($7.8M AUD) yearly recurring revenue in FY2020.
• Back in 2017 ONE was capped at $330M. The tech, business, team, client base, revenue and partners have all significantly improvedsince then and we still can’t believe ONE is under $100M right now. We think it can achieve its heights again soon.
• Back when ONE was capped much higher they raised and invested over $100M in their tech - we think the current valuation is not reflecting this, great for investors like us looking for value.
• Recent Samsung agreement and long standing Microsoft partnership could further push revenues north as its Cloud product starts to deliver.
• ONE had $10.5M in the bank on December 31st 2020. With a current market cap of $100M, we think this is still an excellent enterprise value of ~ $90M.

We have developed a strong relationship with management and believe that this company is on the cusp of something big.

In short, we feel the company will only continue its current momentum (revenues growing, costs shrinking) as seen below:

Worth accumulating imo Is a real business not based on Hype like 99% of small caps